These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8866230)

  • 21. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
    Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
    Gerhard M; Juhl H; Kalthoff H; Schreiber HW; Wagener C; Neumaier M
    J Clin Oncol; 1994 Apr; 12(4):725-9. PubMed ID: 7512130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
    Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
    Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
    Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
    Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
    Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction.
    Schoenfeld A; Luqmani Y; Smith D; O'Reilly S; Shousha S; Sinnett HD; Coombes RC
    Cancer Res; 1994 Jun; 54(11):2986-90. PubMed ID: 8187086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
    Krüger W; Krzizanowski C; Holweg M; Stockschläder M; Kröger N; Jung R; Mross K; Jonat W; Zander AR
    J Cancer Res Clin Oncol; 1996; 122(11):679-86. PubMed ID: 8898979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction.
    Li BD; Harlow SP; Budnick RM; Sheedy DL; Stewart CC
    Cancer; 1994 Jun; 73(11):2771-8. PubMed ID: 7514954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
    Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
    Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination.
    Ballestrero A; Coviello DA; Garuti A; Nencioni A; Famà A; Rocco I; Bertorelli R; Ferrando F; Gonella R; Patrone F
    Cancer; 2001 Oct; 92(8):2030-5. PubMed ID: 11596016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction.
    Gunn J; McCall JL; Yun K; Wright PA
    Lab Invest; 1996 Oct; 75(4):611-6. PubMed ID: 8874391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
    Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
    Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.